BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8899311)

  • 1. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
    Jin YM; Nowicky JW; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
    Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
    Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Ukrain on immunological blood parameters in vitro and in vivo.
    Nowicky JW; Hiesmayr W; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):163-5. PubMed ID: 8899322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain (NSC-631570) in experimental and clinical studies: a review.
    Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
    Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
    Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma.
    Voltchek IV; Liepins A; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):283-6. PubMed ID: 8899349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
    Boyko VN; Zholus RB
    Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta2 adrenoceptor agonists on T-cell subpopulations.
    Holen E; Elsayed S
    APMIS; 1998 Sep; 106(9):849-57. PubMed ID: 9808411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Ukrain on human xenografts in vitro.
    Nowicky JW; Hiesmayr W; Nowicky W; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):93-7. PubMed ID: 8899310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
    Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
    Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
    Liepins A; Nowicky JW; Bustamante JO; Lam E
    Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase.
    Wesch D; Marx S; Kabelitz D
    J Immunol; 1998 Aug; 161(3):1248-56. PubMed ID: 9686585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of CD69 antigen on normal CD4+ and CD8+ lymphocyte subsets and its relationship with the phenotype of responding T-cells.
    Rutella S; Rumi C; Lucia MB; Barberi T; Puggioni PL; Lai M; Romano A; Cauda R; Leone G
    Cytometry; 1999 Jun; 38(3):95-101. PubMed ID: 10397327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N; Plasswilm L; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
    Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
    Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.